ImmunityBio (IBRX) Q2 2026 Earnings Report

2,600 Followers

IBRX Q2 2026 EPS Results

Actual EPS-$0.22

Consensus EPS-$0.08

Beat/MissMissed by -$0.14

One Year Ago EPS-$0.10

Actual Revenue$51.24M

Expected Revenue$49.70M

Beat/MissBeat by +$1.54M

YoY Revenue Growth+93.91%

QuarterQ2 2026

Date08/04/2026

TimeBefore Open

Conference CallTuesday, August 4, 2026

IBRX Upcoming Earnings

ImmunityBio's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.07 / -	-0.07	―
Aug 04, 2026	2026 (Q2)	-0.08 / -0.22	-0.1	-120.00% (-0.12)
May 07, 2026	2026 (Q1)	-0.07 / -0.62	-0.15	-313.33% (-0.47)
Mar 03, 2026	2025 (Q4)	-0.08 / -0.06	-0.09	33.33% (+0.03)
Nov 04, 2025	2025 (Q3)	-0.11 / -0.07	-0.14	50.00% (+0.07)
Aug 05, 2025	2025 (Q2)	-0.11 / -0.10	-0.2	50.00% (+0.10)
May 12, 2025	2025 (Q1)	-0.13 / -0.15	-0.2	25.00% (+0.05)
Mar 03, 2025	2024 (Q4)	-0.20 / -0.09	-0.36	75.00% (+0.27)
Nov 12, 2024	2024 (Q3)	-0.18 / -0.14	-0.19	26.32% (+0.05)
Aug 09, 2023	2023 (Q2)	-0.23 / -0.32	-0.24	-31.25% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed